Viracta Therapeutics Net Tangible Assets

Viracta Therapeutics (VIRX) currently reports a net tangible assets of $-6.6M as of September 2024. That compares with $30M in the prior-year period — down 122.1% year over year. Use the charts on this page to explore Viracta Therapeutics's net tangible assets history and peer comparisons.

Viracta Therapeutics's net tangible assets decreased from $30M to $-6.6M — a 122.1% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Viracta Therapeutics reported $-6.6M in net tangible assets as of September 2024. That compares with $30M in the prior-year period — down 122.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-6.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Viracta Therapeutics, and consider following VIRX for alerts when major investors trade the stock.

Viracta Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $-6.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VIRX with unrelated industries.